Caracterización funcional de mecanismos oncogénicos en neoplasias linfoides
Publicaciones destacadas
-
Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models
Singh, Satishkumar; Wang, Yuanfeng; Sircar, Anuvrat; Jindal, Udita; Srour, Noura;(...)Alinari, Lapo; Peterson, Blake R; Epperla, Narendranath; Jain, Neeraj; Sehgal, Lalit.Referencia:Biomark Res 2026.
-
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4.5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the
Dreyling, Martin; Doorduijn, Jeanette; Gine, Eva; Jerkeman, Mats; Walewski, Jan;(...)Schmidt, Christian; Unterhalt, Michael; Tix, Tobias; Ladetto, Marco; Hoster, Eva.Referencia:LANCET 2026.
-
The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma
De Bolos, Anna; Carreras-Caballe, Maria; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor; Charalampopoulou, Stella;(...)Martin-Subero, Jose, I; Campo, Elias; Reverter, David; Villanueva, Josep; Amador, Virginia.Referencia:Blood Cancer Journal 2025.
-
SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features
Sureda-Gomez, Marta; Iaccarino, Ingram; De Bolos, Anna; Meyer, Mieke; Balsas, Patricia;(...)Leoncini, Lorenzo; Campo, Elias; Siebert, Reiner; Amador, Virginia; Klapper, Wolfram.Referencia:BLOOD 2024.
-
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma
Morsy, MHA; Lilienthal, I; Lord, M; Merrien, M; Wasik, AM;(...)Taylor, IA; Christensson, B; Campo, E; Herold, N; Sander, B.Referencia:BLOOD 2024.
-
SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma
De Bolòs, A; Sureda-Gómez, M; Carreras-Caballé, M; Rodríguez, ML; Clot, G;Beà, S; Giné, E; Campo, E; Balsas, P; Amador, V.Referencia:Scientific Reports 2024.
-
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
Sureda-Gomez, Marta; Balsas, Patricia; Rodriguez, Marta-Leonor; Nadeu, Ferran; De Bolos, Anna;(...)Jares, Pedro; Martin-Subero, Jose, I; Bea, Silvia; Campo, Elias; Amador, Virginia.Referencia:LEUKEMIA 2023.
-
SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
Balsas, Patricia; Veloza, Luis; Clot, Guillem; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor;(...)Engel, Pablo; Quintanilla-Martinez, Leticia; Klapper, Wolfram; Campo, Elias; Amador, Virginia.Referencia:BLOOD 2021.
-
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death
Domostegui, Ana; Peddigari, Suresh; Mercer, Carol A; Iannizzotto, Flavia; Rodriguez, Marta L;(...)Kang, Jian; Gentilella, Antonio; Pearson, Richard B; Thomas, George; Pelletier, Joffrey.Referencia:BLOOD 2021.
-
Increased Tumor Angiogenesis in SOX11-positive Mantle Cell Lymphoma
Petrakis, Georgios; Veloza, Luis; Clot, Guillem; Gine, Eva; Gonzalez-Farre, Blanca;(...)Martinez, Antonio; Lopez-Guillermo, Armando; Amador, Virginia; Ribera-Cortada, Inmaculada; Campo, Elias.Referencia:HISTOPATHOLOGY 2019.
